Barrett & Company’s AbbVie ABBV Stock Holding History

Barrett & Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$682K	Sell	2,709 -250	-8%	-$53.8K	0.19%	80
2026 Q1	$644K	Hold	2,959	–	–	0.22%	69
2025 Q4	$676K	Hold	2,959	–	–	0.23%	68
2025 Q3	$685K	Hold	2,959	–	–	0.23%	68
2025 Q2	$549K	Hold	2,959	–	–	0.21%	76
2025 Q1	$620K	Hold	2,959	–	–	0.27%	66
2024 Q4	$526K	Buy	2,959 +12	+0.4%	+$2.21K	0.22%	75
2024 Q3	$582K	Hold	2,947	–	–	0.25%	69
2024 Q2	$505K	Sell	2,947 -50	-2%	-$8.28K	0.23%	74
2024 Q1	$546K	Hold	2,997	–	–	0.26%	67
2023 Q4	$464K	Sell	2,997 -49	-2%	-$7.14K	0.25%	78
2023 Q3	$454K	Buy	3,046 +1	+0%	+$147	0.27%	73
2023 Q2	$410K	Buy	3,045 +651	+27%	+$95.5K	0.24%	82
2023 Q1	$382K	Buy	2,394 +1	+0%	+$153	0.24%	81
2022 Q4	$387K	Hold	2,393	–	–	0.26%	78
2022 Q3	$387K	Buy	+2,393	New	+$343K	0.26%	78

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Barrett & Company's ABBV Position: Q2 2026 in Review

Barrett & Company reduced its AbbVie (ABBV) stake by 8.4% in Q2 2026, selling an estimated $53.8K and leaving 2,709 shares worth $682K. The position accounts for 0.19% of the portfolio, ranked #80.

Barrett & Company first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. The position peaked at $685K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Barrett & Company held 2,709 shares of AbbVie worth $682K as of Q2 2026.
Barrett & Company sold 250 AbbVie shares in Q2 2026, an estimated $53.8K.
AbbVie made up 0.19% of Barrett & Company's portfolio in Q2 2026, its #80 holding.
Barrett & Company first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
Barrett & Company's AbbVie position peaked at $685K in Q3 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.